Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Trading Update

8 Sep 2021 09:36

RNS Number : 1062L
B&M European Value Retail S.A.
08 September 2021
 

 

 

 

8 September 2021

B&M European Value Retail S.A.

 

H1 FY22 Trading Update

 

 

B&M European Value Retail S.A. ("the Group"), the UK's leading variety goods value retailer, today provides a trading update relating to its performance to date for the half year ending 25 September 2021 ("H1 FY22").

 

Whilst Group revenues year to date have been broadly in line with market expectations, gross margins have been stronger than originally anticipated in the B&M UK fascia business.

 

Performance of General Merchandise and Seasonal categories has been particularly encouraging. Sell-through rates in those categories have been high and accordingly end of season markdowns have been limited.

 

As a consequence, the Group now expects adjusted EBITDA1 (on a pre-IFRS16 basis) for H1 FY22 (covering the 26 week period to 25 September 2021) to be in the range of £275m to £285m. The analysts' consensus estimate2 for H1 FY22 adjusted EBITDA1 is currently approximately £235m.

 

Although the Group is well positioned for the upcoming Golden Quarter, trading patterns and strength of customer demand remain highly uncertain for the balance of FY22.

 

The Group will provide further detail in its FY22 Interim Results on 11 November 2021.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

 

1. The Directors consider adjusted EBITDA figures to be more reflective of the underlying business performance of the Group and believe that this measure provides additional useful information for investors on the Group's performance. Adjusting items are the effects of derivatives, one off refinancing fees, foreign exchange on the translation of intercompany balances and the effects of revaluing or unwinding balances related to the acquisition of subsidiaries.

2. The consensus estimate for adjusted EBITDA in H1 FY22 is based upon the average of 10 analysts who have provided estimates for that period.

 

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext 5763

Simon Arora, Chief Executive

Alex Russo, Chief Financial Officer

Jonny Armstrong, Head of Investor Relations

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Sam Cartwright, Maitland

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGIGDCXXGDGBI
Date   Source Headline
14th Nov 20235:52 pmRNSPricing of £250 Million Senior Secured Notes
13th Nov 20232:28 pmRNSPre Stabilisation Notice
13th Nov 20239:39 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:30 amRNSTender Offer
13th Nov 20239:27 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:07 amRNS£250 Million Senior Secured Notes Offering
9th Nov 20237:00 amRNSFY24 Interim Results
3rd Oct 20237:25 amRNSTotal Voting Rights
22nd Sep 202311:33 amRNSDirector Appointment and Results of OGM
19th Sep 20238:50 amRNSTiming of announcement of Half Year Results
7th Sep 20232:19 pmRNSNotification of major holdings
7th Sep 20231:31 pmRNSDirector/PDMR Shareholding
5th Sep 20239:48 amRNSAcquisition of Assets from Wilko Ltd (in admin)
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Aug 20239:08 amRNSNotice of Ordinary General Meeting- replace
14th Aug 20237:00 amRNSNotice of Ordinary General Meeting
9th Aug 20234:02 pmRNSGrant of share options to PDMR
2nd Aug 20239:21 amRNSGrant of options to senior managers
2nd Aug 20239:18 amRNSGrant of options to Directors
28th Jul 20237:00 amRNSGroup Trading Director Retention Agreement
27th Jul 20231:42 pmRNSTR-1 Correction Announcement
26th Jul 20234:15 pmRNSTR-1 Notification of major holdings
26th Jul 20233:33 pmRNSBoard change
26th Jul 20238:45 amRNSEGM Voting results announcement
26th Jul 20238:15 amRNSAGM 2023 Voting results announcement
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds
9th Dec 202211:43 amRNSNotice of FY23 Third Quarter Trading Statement
18th Nov 20229:14 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.